• 1
    American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
  • 2
    National Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence, SEER 9 Registries Research Data (1973-2008)—Katrina/Rita Population Adjustment-Linked to Country Attributes, Total US, 1969-2009 Counties, 4-1-0011 [based on the November 2010 submission]. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2010.
  • 3
    Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000; 284: 1954-1961.
  • 4
    Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007; 99: 1384-1394.
  • 5
    Kinsey T, Jemal A, Liff J, Ward E, Thun M. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst. 2008; 100: 1003-1012.
  • 6
    Freeman HP, Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin North Am. 2005; 14: 655-669.
  • 7
    Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R. Factors in quality care—the case of follow-up to abnormal cancer screening tests—problems in the steps and interfaces of care. J Natl Cancer Inst Monogr. 2010; 2010: 58-71.
  • 8
    Freeman HP. Cancer in the socioeconomically disadvantaged. CA Cancer J Clin. 1989; 39: 266-288.
  • 9
    Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9: 222-231.
  • 10
    Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996; 34: 970-984.
  • 11
    Dunmore C, Plummer P, Regan G, Mattingly D, Jackson S, Millikan R. Re: race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 2000; 92: 1690-1691.
  • 12
    Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer. 2000; 89: 561-573.
  • 13
    Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer. 1997; 79: 314-319.
  • 14
    Partridge EE. Elimination of cancer disparities via organizational transformation and community-driven approaches. CA Cancer J Clin. 2011; 61: 5-7.
  • 15
    Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer. 2011; 117( 15 suppl): 3537-3540.
  • 16
    Freeman HP, Wasfie TJ. Cancer of the breast in poor black women. Cancer. 1989; 63: 2562-2569.
  • 17
    Oluwole SF, Ali AO, Adu A, et al. Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community. J Am Coll Surg. 2003; 196: 180-188.
  • 18
    Vargas RB, Ryan GW, Jackson CA, Rodriguez R, Freeman HP. Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer. 2008; 113: 426-433.
  • 19
    Paskett ED, Harrop JP, Wells KJ. Patient navigation: an update on the state of the science. CA Cancer J Clin. 2011; 61: 237-249.
  • 20
    Harold P. Freeman Patient Navigation Institute. Harold P. Freeman Patient Navigation Institute Web site. New York: Harold P. Freeman Patient Navigation Institute; 2011. Available from: Accessed August 1, 2011.
  • 21
    Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008; 85: 114-124.
  • 22
    Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995; 3: 19-30.
  • 23
    Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007; 109( 2 suppl): 359-367.
  • 24
    Psooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004; 55: 145-150.
  • 25
    Markossian TW, Calhoun EA. Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation Project. Health Policy. 2011; 99: 52-59.
  • 26
    Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
  • 27
    Robinson-White S, Conroy B, Slavish KH, Rosenzweig M. Patient navigation in breast cancer: a systematic review. Cancer Nurs. 2010; 33: 127-140.
  • 28
    Ell K, Vourlekis B, Lee PJ, Xie B. Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med. 2007; 44: 26-33.
  • 29
    Christie J, Itzkowitz S, Lihau-Nkanza I, Castillo A, Redd W, Jandorf L. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc. 2008; 100: 278-284.
  • 30
    Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health. 2005; 82: 216-224.
  • 31
    National Breast and Cervical Cancer Early Detection Program (NBCCEDP), Centers for Disease Control and Prevention. NBCCEDP Program Manual: NBCCEDP Policies and Procedures Chapter. Bethesda, MD: Centers for Disease Control and Prevention, NBCCEDP; 2011. Available from: Accessed August 1, 2011.
  • 32
    Colorectal Cancer Control Program, Centers for Disease Control and Prevention. Colorectal Cancer (CRC) Screening Demonstration Program (CRCSDP). Program Policies. Bethesda, MD: Centers for Disease Control and Prevention, CRCSDP; 2006. Available from: Accessed August 1, 2011.
  • 33
    Henson RM, Wyatt SW, Lee NC. The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to 2 major health issues for women. J Public Health Manag Pract. 1996; 2: 36-47.
  • 34
    Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health. 2000; 90: 130-134.
  • 35
    Bureau of Labor Statistics, United States Department of Labor. Consumer Price Index, 2011. Available from: Accessed August 1, 2011.
  • 36
    Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995; 87: 417-426.
  • 37
    Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78-93.
  • 38
    Coburn N, Fulton J, Pearlman DN, Law C, DiPaolo B, Cady B. Treatment variation by insurance status for breast cancer patients. Breast J. 2008; 14: 128-134.
  • 39
    Hassett MJ, Griggs JJ. Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no. J Clin Oncol. 2009; 27: 2120-2121.
  • 40
    Kim J, Jang SN. Socioeconomic disparities in breast cancer screening among US women: trends from 2000 to 2005. J Prev Med Public Health. 2008; 41: 186-194.
  • 41
    Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev. 2003; 60: 294-331.
  • 42
    Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006; 56: 168-183.
  • 43
    Lantz PM, Mujahid M, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006; 96: 2173-2178.
  • 44
    Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a US national survey. Cancer Epidemiol Biomarkers Prev. 2004; 13: 723-732.
  • 45
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999; 353: 1119-1126.
  • 46
    O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004; 96: 1420-1425.
  • 47
    Hoerger TJ, Ekwueme DU, Miller JW, et al. Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med. 2011; 40: 397-404.
  • 48
    National Cancer Policy Board. I. Fulfilling the Potential of Cancer Prevention and Early Detection. Washington, DC: National Academies Press; 2003.
  • 49
    Saini SD, Schoenfeld P, Vijan S. Surveillance colonoscopy is cost-effective for patients with adenomas who are at high risk of colorectal cancer. Gastroenterology. 2010; 138: 2292-2299.
  • 50
    Tangka FK, Subramanian S, Bapat B, et al. Cost of starting colorectal cancer screening programs: results from 5 federally funded demonstration programs [serial online]. Prev Chronic Dis. 2008; 5: A47.
  • 51
    Ell K, Padgett D, Vourlekis B, et al. Abnormal mammogram follow-up: a pilot study women with low income. Cancer Pract. 2002; 10: 130-138.
  • 52
    Haas JS, Brawarsky P, Iyer A, Fitzmaurice GM, Neville BA, Earle C. Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality. Cancer. 2011; 117: 4267-4276.
  • 53
    Dragun AE, Huang B, Tucker TC, Spanos WJ. Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival. Cancer. 2011; 117: 2590-2598.
  • 54
    Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008; 113: 3391-3399.